Search

The European eel has recently been included on the Red List of the International Union for Conservation of Nature (IUCN) as a critically endangered species. The rearing of Anguilla larvae is seen as a key bottleneck to the mass production of glass eels since very little ecological information is available regarding their natural nutrition. Studies of digestive physiology and ontogenetic development in eel larvae could provide useful information for solving some of the puzzles regarding larval fish culture. The aim of this study was to characterize the ontogeny of pancreatic enzymes (trypsin, lipase and amylase) and a peptide hormone regulator of pancreatic secretion (cholecystokinin) in terms of gene expression in European eel larvae from day 0 (P0) of hatching to 5, 10, 15 and 20 days post hatching during fasting. The results in the present study showed that all the genes selected were present, with different levels of expression and increasing trends, during larval development. At P0, the increase in the gene expression of lipase and amylase was higher than that of trypsin and cholecystokinin, confirming that enzymatic activity began before mouth opening and that larvae, provided with a complete enzymatic set, might have the capacity of digesting and absorbing various nutrients.

This investigation focused on an episode of chronic mortality observed in juvenile Huso huso sturgeons. The examined subjects underwent pathological, microbiological, molecular, and chemical investigations. Grossly severe body shape deformities, epaxial muscle softening, and multifocal ulcerative dermatitis were the main observed findings. The more constant histopathologic findings were moderate to severe rarefaction and disorganization of the lymphohematopoietic lymphoid tissues, myofiber degeneration, atrophy and interstitial edema of skeletal epaxial muscles, and degeneration and atrophy of the gangliar neurons close to the myofibers. Chemical investigations showed a lower selenium concentration in affected animals, suggesting nutritional myopathy. Other manifestations were nephrocalcinosis and splenic vessel wall hyalinosis. Septicemia due to bacteria such as Aeromonas veronii, Shewanella putrefaciens, Citrobacter freundii, Chryseobacterium sp., and pigmented hyphae were found. No major sturgeon viral pathogens were detected by classical methods. Next-generation sequencing (NGS) analysis confirmed the absence of viral pathogens, with the exception of herpesvirus, at the order level, also, the presence of Aeromonas veronii and Shewanella putrefaciens was confirmed at the family level by the metagenomic classification of NGS data. In the absence of a primary yet undetected biological cause, it is supposed that environmental stressors, including nutritional imbalances, may have led to immune system impairment, facilitating the entry of opportunistic bacteria and mycotic hyphae.

The reproductive performances of silver European eel in term of gonad development and egg production, employing slow-release implants with the androgen 17-MT (1Â mg) in combination with traditional weekly injection of carp pituitary extract (CPE) was evaluated. Wild female European eels (Anguilla anguilla) underwent a standard induction protocol with CPE and were randomly divided into three groups (N-group, no implant; Y-group, with implant; and control, C-group, no treatment). The results showed that 17-MT-treated females (Y-group) reproduced spontaneously about 6 weeks earlier than the N-group females with a saving of almost 40% in CPE and time of induction. Concerning artificial induction of maturation in female silver eels, our study demonstrated that they positively respond to androgen exposure also in terms of eggs productivity. Indeed, Y-group was more productive than N-group: in Y-group, 11 eels ensured an eggs production that exceeded 50% of initial body weight (BW), whereas in N-group only three eels have exceeded this value. The results suggest that 17-MT should be considered in future protocols for the improvement of the artificial reproduction of female silver European eels.

Enrofloxacin (EF) is a veterinary drug for respiratory, gastrointestinal and urinary tract infections. Parenteral administration at doses higher than the manufacturer recommended dosage has induced cartilage lesions in juvenile mammals and poultry. In elasmobranchs EF is commonly used for the treatment of infectious diseases, however only one study has been performed previously to evaluate pharmacokinetics and the potential chondrotoxicity of a fluoroquinolone in adult skates. In present study juvenile lesser spotted dogfish (Scyliorhinus canicula, Linnaeus, 1758) were treated with low (LD, 5 mg/kg) and high dose (HD, 10 mg/kg) of EF daily via intramuscular injection for 15 consecutive days, as indicated in a recognized treatment. Hematological parameters, oxidative stress and histology of vertebral cartilage were evaluated. No cartilage damage was observed. Hematological parameters evaluation underlined a significant (p = 0.035), dose-dependent reduction in red blood cell count and in hematocrit (40% and 6%, respectively). Anyway, the biological significance of this reduction is doubtful, due to limited decrease observed. The evaluation of oxidative stress parameters underlined that glutathione levels, as well as glutathione S-transferase and catalase activities, were significantly increased in HD group animals, with respect to untreated and solvent control groups. Obtained data do not support a toxic effect of EF on dogfish cartilage, while concern arises from hematological and oxidative stress data.

Inclusion of sustained-release androgen implants into fertility treatment regimes of female freshwater eels has been proposed to benefit artificial maturation outcomes. This study sought to test whether co-administration of the androgen 17-methyltestosterone (17-MT) in combination with ‘traditional’ hypophysation of female European silver eels would affect egg quality and subsequent larval survival. Implants, containing 1 mg 17-methyltestosterone (17α-methyl-4-androsten-17β-ol-3-one in a matrix of cholesterol:cellulose = 95:5), were administered twice, at 1 and 5 weeks after onset of experimentation (MTA- and MTB-groups); control eels (Ctrl) were given a blank implant. Female eels received weekly injections with carp pituitary homogenates (CPH) from either Week 1 (MTA- and Ctrl groups) or Week 5 onwards (MTB-group). First 4 injections were made with 10 mg CPH/kg body weight (BW) in sterile physiological saline (0.9% NaCl); the subsequent 12 injections with 30 mg/kg CPH and thereafter, 40 mg/kg CPH was injected until fish were considered ready for induction of final maturation. Bi-weekly blood samples were collected (Day 0 onwards) and analyzed for levels of testosterone (T) and estradiol-17β (E2) by radioimmunoassay. After reaching maturity, fertilized eggs were obtained upon spontaneous spawning of co-housed breeders and egg performance (fertilization, hatching, survival rates) was recorded. No differences were observed between eels from the MTA- and MTB-groups; however, egg performance was notably better in eels treated with 17-MT + CPH compared to eels receiving CPH only, with hatching rates reaching mean values as high as around 70% for both 17-MT and CPH co-treated groups, but only averaging 21.0 ± 8.4% for eggs from the Ctrl-group. Furthermore, 17-MT treated eels displayed a more distinct pre-spawning peak for levels of plasma T and E2 and for body weight, the latter being indicative of increased batch fecundity. We conclude that androgen co-treatment holds promise for future development of eel captive breeding technologies. Statement of relevance Artificial propagation of the European eel is increasingly urgent to release the strain on natural populations. This study presents a novel approach to artificial maturation of female eels: centered around the incorporation of androgens during fertility treatment. Accordingly, increased performance was observed in terms of fertilization, hatching and survival rates, which contributes to completing the life cycle of this fish in captivity. © 2017 Elsevier B.V.

Florfenicol (FF) is employed in fish farms to contest or prevent bacterial infections. However, this pharmaceutical may produce reactive oxygen species that may cause biochemical changes in antibiotic-treated fish. The aim of this study was to evaluate the effect of FF on Rainbow Trout Oncorhynchus mykiss treated for 10 d with 7.5 and 15 mg/kg FF followed by a withdrawal period of 5 d. Superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione S-transferase, glyoxalase I and glyoxalase II, total glutathione, lactic dehydrogenase, and alkaline phosphatase were investigated in the livers of treated and untreated fish. A general impairment of antioxidant enzymes and metabolic indicators was measured in FF-treated Rainbow Trout. Onset of oxidative damage may have occurred during the antibiotic treatment as a consequence of the effect of FF toxicity at mainly the highest dose. Nevertheless, the rise in levels of total glutathione and glutathione S-transferase even after the withdrawal period may shield the antibiotic-mediated oxidative processes. Received December 22, 2015; accepted May 26, 2016.

Nonylphenol, an estrogenic-like compound, can induce vitellogenin synthesis in males and immature Teleostean species, but little is known about its effects on thyroid hormones balance. The present study evaluated the potential effects of a single acute exposure to nonylphenol (i.p. injected) on the thyroid and reproductive axis of 250 shubunkins (Carassius auratus). Plasma levels of thyroid hormones were quantified immunoenzymatically by ELISA assay. Nonylphenol induced a significant decrease of thyroxin levels, whereas no effect on triiodothyronine concentrations was detected. No histopathological changes were detected in thyroid or testes. The toxicological data confirmed that nonylphenol exerts an estrogenic effect on male fish. In addition, nonylphenol was suspected to inhibit the thyroid hormones balance, suggesting the thyroid should be included among the other endocrine glands susceptible to endocrine disruption.

Summary Seabass (SBS) and seabream (SBM) juveniles were reared with the goal of obtaining three different final densities (SINT = 40 kg m−3; INT = 20 kg m−3; SEM = 0.2 kg m−3) to ascertain the effects thereof on the welfare of the fish. Significant blood metabolites and hepatic glycogen were determined every 3 months and at harvest. Trials lasted 18 months in seabass and 17 months in seabream. At the end of experiment the main biometric productive parameters and quality of body composition were also recorded. Regarding intensively reared seabass (SINT-SBS, INT-SBS), the plasma triglycerids, total cholesterol and transaminases (AST, ALT) were always significantly higher than in semi-intensively maintained fish (SEM-SBS). At the final sampling in the SINT-SBS batch, the total protein and glucose were also markedly increased. Conversely, at harvest the liver glycogen content decreased in SINT-SBS (34 ± 8 mg g−1 liver) with respect to INT-SBS (57 ± 12 mg g−1 liver) and SEM-SBS (63 ± 11 mg g−1 liver). No differences among groups were observed for creatine kinase (CK) and lactate dehydrogenase (LDH). With regard to seabream, SINT-SBM and INT-SBM constantly showed plasma triglycerids and total cholesterol as being significantly higher when compared to SEM-SBM. In the final two blood samplings, SINT-SBM exhibited the most elevated values for LDH. At harvest, AST, ALT, total protein and glucose markedly increased in SINT-SBM, whereas liver glycogen content was reduced (22.5 ± 9 mg g−1 liver), more than in INT-SBM (70 ± 16 mg g−1 liver) and SEM-SBM (75 ± 20 mg g−1 liver). In both seabass and seabream, body composition was very similar in the different stocking densities, except for total cholesterol. Total n-3 polyunsaturated fatty acid (PUFA) in seabream was significantly different from fish of the semi-intensive groups; however, nutritional values and fatty acid profiles were equally good. The intermediate final density of seabass and seabream at 20 kg m−3 seemed to give the best results in terms of their well being when compared to fish reared at 40 kg m−3. The absence of differences in blood metabolites and hepatic glycogen levels between the intensive batch and the semi-intensive groups until harvest was a reference to the positive status of the fish. A density of 20 kg m−3 can be considered acceptable for farm strategy planning for raising healthy on-growing seabass and seabream juveniles.

Growth performances of sunshine bass (initial m.b.w.=200±50 g) were examined in 3 different rearing conditions: concrete square basins (HSB-1); raceways (HSB-2); natural ponds (HSB-3). Fish received the same extruded feed (prot. 48.8%; lip. 17.8%). The trial lasted 16 months in HSB-1 and HSB-2 and only 12 months in HSB-3 due to unfavourable welfare status and low growth performances. At harvest (after 16 months), sunshine bass reached a satisfactory mean weight with- out significant differences between groups. HSB-2 fish were longer with a smaller circumference, prob- ably due to different hydrodynamics of the raceway. Glucose, cholesterol, triglycerides, protein, lactic dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), creatine kinase (CK), glycogen of plasma or tissue were not affected by rearing conditions as well as the proximate composition and the fatty acid profile of the fillet.